1Suppliers
0Customers
3Debt Items
0Related Chains

Telomir Pharmaceuticals, Inc. Suppliers

TickerNameConfidenceEvidence
BAYSHORE-TRUST BAYSHORE-TRUST 90% As a condition to closing, Bayshore Trust, a shareholder of TELI, contributed $1 million at closing to the Company

Telomir Pharmaceuticals, Inc. Customers

No clients on recordNo downstream customers found in our database for Telomir Pharmaceuticals, Inc..

Telomir Pharmaceuticals, Inc. Debt Obligations

InstrumentDescriptionConfidenceEvidence
TELO-DEBT-12935 Warrants outstanding: 7 90% xbrl warrant detail from xbrl 2024-12-31.
TELO-DEBT Debt stack $202,869 90% Market cache reports total debt of $202,869.
TELO-DEBT-12936 Xbrl Convertible 90% xbrl convertible detail from xbrl 2023-12-31.

Telomir Pharmaceuticals, Inc. Acquisitions

Acquired EntityNameConfidenceEvidence
TELO-ACQ-0001493152-26-018867 Telomir Pharmaceuticals, Inc. issued 34,389,710 restricted shares to acquire TELI Pharmaceutical... 85% Telomir Pharmaceuticals, Inc. issued 34,389,710 restricted shares to acquire TELI Pharmaceuticals, Inc.

Telomir Pharmaceuticals, Inc. Ownership

HolderNameConfidenceEvidence
TELO-OWNER-VANGUARD-CAPITAL-MANAGEMENT-LLC VANGUARD CAPITAL MANAGEMENT LLC 90% 13F overlay lists VANGUARD CAPITAL MANAGEMENT LLC as top holder; 30 tracked holders.

Telomir Pharmaceuticals, Inc. Extended Supply Chain Network

No secondary connectionsNo correlated companies found through shared supply chain relationships.